Prevent 6:1 Trial

Cross-source consensus on Prevent 6:1 Trial from 1 sources and 5 claims.

1 sources · 5 claims

Evidence quality

The trial is not powered to demonstrate changes in weight, diet, or physical activity. — Prevent 6:1 trial: pI rotocol for a feasibility trial of a 6:1 intermittent diet for weight gain prevention in women at increased risk of breast cancer
The Prevent 6:1 trial is a single-arm prospective feasibility trial in women aged 18 to 40 with normal BMI and elevated breast cancer risk. — Prevent 6:1 trial: pI rotocol for a feasibility trial of a 6:1 intermittent diet for weight gain prevention in women at increased risk of breast cancer
The planned Prevent 6:1 trial period runs from March 17, 2025 to March 17, 2026. — Prevent 6:1 trial: pI rotocol for a feasibility trial of a 6:1 intermittent diet for weight gain prevention in women at increased risk of breast cancer
The trial recruits participants through MFT family history and cancer genetics clinics and charity-based promotion. — Prevent 6:1 trial: pI rotocol for a feasibility trial of a 6:1 intermittent diet for weight gain prevention in women at increased risk of breast cancer
The sample size of 30 participants was chosen to estimate feasibility outcomes with acceptable precision. — Prevent 6:1 trial: pI rotocol for a feasibility trial of a 6:1 intermittent diet for weight gain prevention in women at increased risk of breast cancer